Related Experiment Video
Updated: Jul 1, 2025

10:35
Stereotactic Radiosurgery for Gynecologic Cancer
Published on: April 17, 2012
18.2K
Optimizing Palliative Pelvic Radiotherapy in Gynecological Cancers: A Systematic Review and Analysis
Beatrice Anghel1, Mihai-Teodor Georgescu2, Crenguta Sorina Serboiu3
1Faculty of Medicine, "Carol Davila" University of Medicine and Pharmacy, 020021 Bucharest, Romania.
Diagnostics (Basel, Switzerland)
|March 13, 2024
Summary
Palliative pelvic radiotherapy effectively manages symptoms in gynecological cancers (GCs), particularly bleeding and pain. Further research is needed to optimize dosing and fractionation for improved patient outcomes.
Area of Science:
- Oncology
- Radiotherapy
- Gynecologic Oncology
Background:
- Palliative radiotherapy is vital for symptomatic gynecological cancers (GCs).
- Systematic review of palliative pelvic radiotherapy for cervical, endometrial, ovarian, vaginal, and vulvar cancers.
- Focus on symptom relief, quality of life (QOL), and toxicity.
Purpose of the Study:
- To systematically review literature on palliative pelvic radiotherapy for GCs.
- Evaluate symptom relief, QOL, and toxicity.
- Ascertain optimal radiotherapy regimens.
Main Methods:
- Medline search for papers published until November 2023.
- Selection of studies detailing symptomatology and QOL in palliative pelvic radiotherapy for GCs.
Main Results:
- Thirty-one studies reviewed, many retrospective with varied outcomes.
- Effective management of hemorrhage (55%) and pain control (70%).
- 10 Gy fractionation showed benefits for bleeding and pain in female genital tract cancers.
Conclusions:
- Palliative pelvic radiotherapy is effective for symptomatic GCs.
- Dosing and fractionation require further investigation.
- Combining modern therapies with radiotherapy improves symptom control for selected patients.
Related Concept Videos
Cancer Therapies
7.7K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.7K
Cancer Survival Analysis
345
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
345

